Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
31 participants
INTERVENTIONAL
2020-02-04
2023-06-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Controlled Phonation and Vocal Rest Programs After Acute Vocal Exertion in Healthy Adults
NCT03762993
Prevention and Treatment of Voice Problems in Teachers
NCT01199172
Preliminary Study 2 to Test the Effects of Ambulatory Voice Biofeedback
NCT03416868
Straw Phonation Exercise Program for Pitch Extension
NCT05357222
Dysphonia, Distress, and Perceived Control: Technology Based Assessment and Intervention
NCT03576365
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cardiovascular Conditioning Protocol
Participants will complete a sub maximal cardiovascular training program twice per week for a period of 4 weeks.
Cardiovascular Conditioning Protocol
Participants will be randomized to either one of the treatment arms to receive treatment for a period of 4 weeks.
Voice Production Exercises
Participants will complete voice production exercises twice per week for a period of 4 weeks.
Voice Production Exercises
Participants will be randomized to either one of the treatment arms to receive treatment for a period of 4 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cardiovascular Conditioning Protocol
Participants will be randomized to either one of the treatment arms to receive treatment for a period of 4 weeks.
Voice Production Exercises
Participants will be randomized to either one of the treatment arms to receive treatment for a period of 4 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A score of ≥ 15 on factor 1 of the VFI (tiredness and avoidance of voice use) or a score of ≤ 5 on factor 3 of the VFI (improvement of symptoms or lack thereof with rest)
* Sedentary- wherein participants will need to be completing mild intensity cardiovascular exercise less than 150 minutes in less than 5 days per week
Exclusion Criteria
* Trained singers
* Smoking in the past 6months
* Prior history of a vocal fold pathology and current vocal fold pathology
21 Years
60 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
East Tennessee State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chayadevie Nanjundeswaran
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
East Tennessee State University
Johnson City, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0819.1s-ETSU
Identifier Type: OTHER
Identifier Source: secondary_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.